StockData
DataMeds AI, Inc. logo

DataMeds AI, Inc. (MEDS) stock

MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.74+0.10 (+15.41%)

Close on Nov 18, 2026Market cap $2.26MP/E –Yield –

DataMeds AI operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

DataMeds AI's operating income for the twelve months ending Sep 30, 2026 was -$42.09M. For fiscal 2025 it was -$93.75M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$93.75M–
FY2024Dec 31, 2024-$6.15M–
FY2023Dec 31, 2023-$2.88M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$3.37M–
Q2 FY2026Jun 30, 2026-$7.35M–
Q1 FY2026Mar 31, 2026-$6.02M–
Q4 FY2025Dec 31, 2025-$25.35M–
Q3 FY2025Sep 30, 2025-$31.55M–
Q2 FY2025Jun 30, 2025-$5.50M–
Q1 FY2025Mar 31, 2025-$31.35M–
Q4 FY2024Dec 31, 2024-$3.75M–
Q3 FY2024Sep 30, 2024-$1.74M–
Q2 FY2024Jun 30, 2024-$573.02K–
Q1 FY2024Mar 31, 2024-$79.76K–

More DataMeds AI figures

See a number that looks wrong?